ACS Report Shows Prostate Cancer on the Rise, Cervical Cancer on the Decline
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Diagnosis & Disease Information
Monoclonal Antibody Granted Orphan Drug Status for Pancreatic Cancer
ZB131 is a proprietary monoclonal antibody designed to target cancer-specific plectin with high affinity and specificity.
Improving Cancer Care for Transgender Patients
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.
Test May Improve Early Detection of Pancreatic Cancer
The gene sequencing panel PancreaSeq can accurately classify pancreatic cysts as benign or potentially cancerous, according to researchers.
Oral CDK7 Inhibitor Granted Orphan Drug Status for Pancreatic Cancer
SY-5609 is a highly selective and potent oral inhibitor of the cyclin-dependent kinase 7.
Results of Pancreatic Cancer Trials Are Not Being Published
Researchers found that 30% of pancreatic adenocarcinoma trials completed from 2010 through 2020 did not have results available.
Adaptive Dynamic Therapy Improves Survival in Pancreatic Cancer
Perioperative adaptive dynamic therapy can improve overall survival in patients with localized pancreatic cancer, new research suggests.
Neoadjuvant Chemoradiotherapy Improves Long-Term OS in Pancreatic Cancer
In addition to improved overall survival, patients in the neoadjuvant arm had longer disease-free survival and locoregional failure-free intervals.
Opioid Use Linked to Survival in Older Patients With Advanced Pancreatic Cancer
The median survival was significantly longer in patients who received opioid prescriptions than in those who did not.
COVID-19 Pandemic Did Not Affect Care of Pancreatic Cancer Patients
Patients with pancreatic ductal adenocarcinoma may have been spared the COVID-related delays in care seen for other cancers, according to researchers.
- Loading...
Loading...
Next post in Oncology
Loading... 
Loading...